Company news

Nirvana Life Sciences Inc news in 2022

Nirvana Life Sciences Inc's news releases, calls and decks from 2022, newest first.

View company

Nirvana Life Sciences Inc. announces agreement to acquire the licensed distributor of a Patented, WHO approved, herbal treatment for opiate addiction

November 21, 2022

Nirvana Life Sciences Inc. Deuterates 7-Hydroxymitragynine to Create D7-h, an Analogue that May Improve Research and Formulations using Kratom Derivatives

September 22, 2022

Nirvana Life Sciences Inc. Announces a Method for Producing MDMA that Reduces Manufacturing Time by Two Thirds

September 7, 2022

Nirvana Life Sciences Inc. Announces License for a Delivery System for Psychedelic APIs

July 6, 2022

Nirvana Life Sciences Announces Approval To Build Vancouver Facility From Health Canada

June 28, 2022

Nirvana Life Sciences announces filing of Patent for novel isolation of 4-PO-Psilocin Prodrug Compound

June 23, 2022

Nirvana Life Sciences Announces Patent Filing

June 9, 2022

Nirvana Life Sciences Announces Positive Results for Addiction Relapse Prevention from Their Latest Pre-Clinical Psychedelic Drug Study

June 2, 2022

Nirvana Life Sciences Inc. Announces the appointment of Andrew Samann to Advisory Board

April 5, 2022

Nirvana enters supply agreement with Symeres

March 29, 2022

Decks in 2022